Avidity Biosciences Inc
(RNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -118,009 | -79,471 | -50,197 | -23,844 | -44,355 |
| Depreciation Amortization | 818 | 518 | 324 | 148 | 382 |
| Other Working Capital | 4,643 | -2,169 | -5,917 | 330 | 2,332 |
| Other Operating Activity | 17,735 | 12,524 | 7,974 | 3,685 | 4,524 |
| Operating Cash Flow | $-94,813 | $-68,598 | $-47,816 | $-19,681 | $-37,117 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -78,777 | 3,580 | 3,580 | N/A | -6,693 |
| PPE Investments | -3,740 | -2,033 | -1,233 | -525 | -1,092 |
| Investing Cash Flow | $-82,517 | $1,547 | $2,347 | $-525 | $-7,785 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -4,683 |
| Common Stock Issued | 176,316 | 166,074 | 440 | 17 | 274,520 |
| Other Financing Activity | 0 | -10,472 | -10 | 0 | 2,200 |
| Financing Cash Flow | $176,316 | $155,602 | $430 | $17 | $272,037 |
| Beginning Cash Position | 321,713 | 321,713 | 321,713 | 321,713 | 94,578 |
| End Cash Position | 320,699 | 410,264 | 276,674 | 301,524 | 321,713 |
| Net Cash Flow | $-1,014 | $88,551 | $-45,039 | $-20,189 | $227,135 |
| Free Cash Flow | |||||
| Operating Cash Flow | -94,813 | -68,598 | -47,816 | -19,681 | -37,117 |
| Capital Expenditure | -3,740 | -2,033 | -1,233 | -525 | -1,092 |
| Free Cash Flow | -98,553 | -70,631 | -49,049 | -20,206 | -38,209 |